Key result
Cardiovascular disease has emerged as a major cause of mortality among breast cancer survivors, driven by shared pre-existing risk factors and the cardiotoxic effects of cancer treatments.
Why the study?
Cardiovascular disease has recently arisen as a non-cancer related cause of mortality among breast cancer survivors, prompting a need to draw attention to this public health problem so new strategies can be implemented.
Highlights the growing importance of cardiovascular disease as a leading cause of non-cancer mortality among breast cancer survivors, emphasizing the need for new preventive strategies.
CVD mortality in breast cancer survivors warrants clinical attention; leaves open prospective strategies for risk reduction.
Objective: Breast cancer (BC) is the most frequent neoplastic disease in women. Recently, cardiovascular disease (CVD) has arisen as a non-cancer related mortality cause between breast cancer survivors. The aim of this paper is to establish the importance of CVD in BC survivors in order to draw attention to this public health problem so new strategies can be implemented in the future. Methods: A PubMed research of the Mesh terms “Breast Neoplasms” and “Heart Disease Risk Factors” was made. Journals available to the Universidad Nacional Autónoma de México – U.N.A.M. (National Autonomous University of México) were revised. Of 130 articles, 52 were selected and were cited for this review. Conclusion: Earlier detection rates and advances in breast cancer therapies have improved overall survival in BC patients. CVD is now an important cause of mortality in BC survivors. This might be explained by the conjunction of pre-existing CVD risk factors and cardiovascular injury secondary to cancer therapy.
No takes yet. Share an insight, caveat, or question.
Gonzalez-Sanchez et al. (2022) conducted a review in Breast cancer. Breast cancer therapies and cardiovascular risk factors was evaluated. Cardiovascular disease has emerged as a major cause of mortality among breast cancer survivors, driven by shared pre-existing risk factors and the cardiotoxic effects of cancer treatments.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: